- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Castle Biosciences Inc (CSTL)
Castle Biosciences Inc stock price live, this page displays NASDAQ CSTL stock exchange data. View the CSTL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Castle Biosciences Inc real time stock price chart below.
What Is the Castle Biosciences Inc Stock Price Today?
The Castle Biosciences Inc stock price today is 19.36.
What Is the Stock Symbol for Castle Biosciences Inc?
The stock symbol for Castle Biosciences Inc is ""CSTL.""
What Stock Exchange Does Castle Biosciences Inc Trade On?
Castle Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Castle Biosciences Inc a Good Stock to Buy?
Determining whether Castle Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSTL quote. (ISIN: US14843C1053)
What Is the Castle Biosciences Inc Stock Price Today?
The Castle Biosciences Inc stock price today is 19.36.
What Is the Stock Symbol for Castle Biosciences Inc?
The stock symbol for Castle Biosciences Inc is ""CSTL.""
What Stock Exchange Does Castle Biosciences Inc Trade On?
Castle Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Castle Biosciences Inc a Good Stock to Buy?
Determining whether Castle Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSTL quote. (ISIN: US14843C1053)
NASDAQ
Currency in USD
19.36
-0.29(-1.48%)
Closed·
After Hours
19.360.00(0.00%)
·
Fair Value
An estimate of a Castle Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.27
20.18
52 wk Range
14.59
35.84
CSTL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CSTL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Castle Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.2720.18
52 wk Range
14.5935.84
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CSTL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Castle Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
36.11
Upside
+86.52%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
6 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Castle Biosciences Inc Company Profile
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a risk stratification spatial-omics test to predict future development of progression of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide optimal drug treatment for patients diagnosed with major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. The company offers its products to skin cancer and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.
Castle Biosciences Inc Earnings Call Summary for Q2/2025
- Castle Biosciences reports Q2 2025 EPS of $0.15, beating -$0.51 forecast; revenue reaches $86.2M, exceeding expectations
- Company raises full-year revenue guidance to $310-320M, up from $287-297M, signaling confidence in future growth
- TissueCypher test reports show 92% YoY increase; company plans to launch new atopic dermatitis test by year-end
- Stock price increased 4.57% to $14.65 during regular trading; InvestingPro analysis suggests stock is currently undervalued
- CEO highlights strong quarter, positioning as leader in dermatologic and gastrointestinal testing franchises
Last Updated: 04/08/2025, 22:42
Read Full TranscriptCompare CSTL to Peers and Sector
Metrics to compare | CSTL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCSTLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −59.3x | −0.1x | −0.5x | |
PEG Ratio | 0.31 | 0.00 | 0.00 | |
Price/Book | 1.2x | 0.4x | 2.6x | |
Price / LTM Sales | 1.6x | 0.5x | 3.3x | |
Upside (Analyst Target) | 83.2% | 43.6% | 43.4% | |
Fair Value Upside | Unlock | 20.8% | 7.1% | Unlock |
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 36.11
(+86.52% Upside)
Earnings
Latest Release
Aug 04, 2025
EPS / Forecast
0.15 / -0.51
Revenue / Forecast
86.19M / 71.43M
People Also Watch
FAQ
What Stock Exchange Does Castle Biosciences Trade On?
Castle Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Castle Biosciences?
The stock symbol for Castle Biosciences is "CSTL."
What Is the Castle Biosciences Market Cap?
As of today, Castle Biosciences market cap is 560.44M.
What Is Castle Biosciences's Earnings Per Share (TTM)?
The Castle Biosciences EPS (TTM) is -0.33.
When Is the Next Castle Biosciences Earnings Date?
Castle Biosciences will release its next earnings report on 09 Nov 2025.
From a Technical Analysis Perspective, Is CSTL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Castle Biosciences Stock Split?
Castle Biosciences has split 0 times.
How Many Employees Does Castle Biosciences Have?
Castle Biosciences has 798 employees.
What is the current trading status of Castle Biosciences (CSTL)?
As of 08 Aug 2025, Castle Biosciences (CSTL) is trading at a price of 19.36, with a previous close of 19.65. The stock has fluctuated within a day range of 19.27 to 20.18, while its 52-week range spans from 14.59 to 35.84.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.